Qbiotix has developed novel nucleic acid assays and sample preparation procedures to improve global microbial detection standards and rapidly/inexpensively test high volume of samples. Qbiotix aims to enable countries to test their entire populations, their food, their waters with millions of tests per day on a regular basis.
The assays are isothermal and homogeneous. Thermocycling is not required and amplification is non-enzymatic removing the need for complex instrumentation and reliance on variable quality enzymes. Critically we have removed the need for complex nucleic acid preparation, integrated the assay into the collection/transport solution and significantly reduced reliance on a complex supply chain. The assays remove a good proportion of the constraints of PCR which heretofore have inhibited the number of people being testing for SARS-CoV-2 in the US and globally.